Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Murine psoriasis-like disorder induced by naive CD4+ T cells

Abstract

Psoriasis is a complex disorder involving alterations of many cell types. Although evidence suggests a T-cell pathogenesis for psoriasis, a primary role of T cells has not been directly demonstrated. Here, we show that reconstitution of scid/scid mice with minor histocompatibility mismatched naive CD4+ T lymphocytes resulted in skin alterations that strikingly resembled human psoriasis clinically, histopathologically and in cytokine expression. This skin disorder was diminished when memory T cells were coinjected. Thus, a subset of dysregulated CD4+ T cells can cause tissue alterations seen in psoriasis without the presence of CD8+ cells or a primary epithelial abnormality.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Christophers, E. & Sterry, W. in Dermatology in General Medicine (eds. Fitzpatrick, T. B., Eisen, A. Z., Wolff, K., Freedberg, I.M. & Austen, K.F.) 489–514 (McGraw-Hill, New York, 1993).

    Google Scholar 

  2. Barker, J.N.W.N. The immunopathology of psoriasis. Bailliere's Clin. Rheumatol. 8, 429–437 (1994).

    Article  CAS  Google Scholar 

  3. Christophers, E. The immunopathology of psoriasis. Int. Arch. Allergy Immunol. 110, 199–206 (1996).

    Article  CAS  PubMed  Google Scholar 

  4. Gottlieb, S.L. et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nature Med. 1, 442–447 (1995).

    Article  CAS  PubMed  Google Scholar 

  5. Carroll, J.M., Romero, M.R. & Watt, F.M. Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis. Cell 83, 957–968 (1995).

    Article  CAS  PubMed  Google Scholar 

  6. Groves, R.W., Mizutani, H., Kieffer, J.D. & Kupper, T.S. Inflammatory skin disease in transgenic mice that express high levels of interleukin 1α in basal epidermis. Proc. Natl. Acad. Sci. USA 92, 11874–11878 (1995).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Wilson, J.B., Weinberg, W., Johnson, R., Yuspa, S. & Levine, A.J. Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 61, 1315–1327 (1990).

    Article  CAS  PubMed  Google Scholar 

  8. Hammer, R.E., Maika, S.D., Richardson, J.A., Tang, J.P. & Taurog, J.D. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human (β2m: An animal model of HLA-B27-associated human disorders. Cell 63, 1099–1112 (1990).

    Article  CAS  PubMed  Google Scholar 

  9. Bullard, D.C. et al. A polygenic mouse model of psoriasiform skin disease in CD18-deficient mice. Proc. Natl. Acad. Sci. USA 93, 2116–2121 (1996).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Sundberg, J.C., Beamer, W.G., Shultz, L.D. & Dunstan, R.W. Inherited mouse mutations as models of human adnexal, cornification, and papulosquamous dermatoses. J. Invest. Dermatol. 95, 62s–63s (1990).

    Article  PubMed  Google Scholar 

  11. Grammer, S.F. & Streilein, J.W. The immune system in cutaneous disease: The search for a mouse model of the immunopathology of psoriasis. in Handbook of Mouse Mutations with Skin and Hair Abnormalities. (ed. Sundberg, J.P.) 143–153 (CRC Press, Boca Raton, FL, 1994).

    Google Scholar 

  12. Powrie, F., Leach, M.W., Mauze, S., Caddie, L.B. & Coffman, R.L. Phenotypically distinct subsets of CD4+ T Cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice. Int. Immunol. 5, 1461–471 (1993).

    Article  CAS  PubMed  Google Scholar 

  13. Morrissey, P.J., Charrier, K., Braddy, S., Liggitt, D. & Watson, J.D. CD4+ T Cells that express high levels of CD45RB induce wasting disease when transferred into congenie severe combined immunodeficient mice. J. Exp. Med. 178, 237–244 (1993).

    Article  CAS  PubMed  Google Scholar 

  14. McGuire, J., Osber, M. & Lightfoot, L. Two keratins MW 50,000 and 56,000 are synthesized by psoriaticepidermis. Br. J. Dermatol. 111, 27–37 (1984).

    Article  CAS  PubMed  Google Scholar 

  15. Bernard, B.A., Reano, A., Darmon, Y.M. & J. Precocious appearance of involucrin and epidermal transglutaminase during differentiation of psoriatic skin. Br. J. Dermatol. 114, 279–283 (1986).

    Article  CAS  PubMed  Google Scholar 

  16. DeLisser, H.M., Newman, P.J. & Albelda, S.M. Molecular and functional aspects of PECAM-1/CD31. Immunol. Today 15, 490–495 (1994).

    Article  CAS  PubMed  Google Scholar 

  17. Detmar, M. et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J. Exp. Med. 180, 1141–1146 (1994).

    Article  CAS  PubMed  Google Scholar 

  18. Keck, P.J. et al. Vascular permeability factor, an endothelial Cell mitogen related to PDCF. Science 246, 1309 (1989).

    Article  CAS  PubMed  Google Scholar 

  19. Finnerty, H. et al. Molecular cloning of murine FLT and FLT4. Oncogene 8, 2293–2298 (1993).

    CAS  PubMed  Google Scholar 

  20. Matthews, W. et al. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic Cells and exhibiting close genetic linkage to c-kit. Proc. Natl. Acad. Sci. USA 88, 9026–9030 (1991).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Birkeland, M.L., Johnson, P., Trowbridge, I.S. & Purz, E. Changes in CD45 isoform expression accompany antigen-induced murine T-Cell activation. Proc. Natl. Acad. Sci. USA 86, 6734–6738 (1989).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Nickoloff, B.J., Griffiths, C.E. & Barker, J.N. The role of adhesion molecules, chemotactic factors, and cytokines in inflammatory and neoplastic skin disease—1990 update. J. Invest. Dermatol. 94, 151S–157S (1990).

    Article  CAS  PubMed  Google Scholar 

  23. Sundberg, J.P., Boggess, D., Shultz, L.D. & Beamer, W.G. The flaky skin (fsn) mutation, chromosome?. in Handbook of Mouse Mutations with Skin and Hair Abnormalities, (ed. Sundberg, J.D.) 253–268 (CRC Press, Boca Raton, 1994).

    Google Scholar 

  24. Nanney, L.B., Sundberg, J.P. & King, L.E. Increased epidermal growth factor receptor in fsn/fsn mice. J. Invest. Dermatol. 106, 1169–1174 (1996).

    Article  CAS  PubMed  Google Scholar 

  25. Kupper, T.S. Immune and inflammatory processes in cutaneous tissues: Mechanisms and speculations. J. Clin. Invest. 86, 1783–1786 (1990).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Frank, S. et al. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. J. Biol. Chem. 270, 12607–12613 (1995).

    Article  CAS  PubMed  Google Scholar 

  27. Grossman, R.M. et al. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc. Natl. Acad. Sci. USA 86, 6367–6371 (1989).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Gottlieb, A.B., Luster, A.D., Posnett, D.N. & Carter, D.M. Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques. J. Exp. Med. 168, 941–948 (1988).

    Article  CAS  PubMed  Google Scholar 

  29. Frater-Schrpder, M., Risau, W., Hallmann, R., Gautschi, P. & Bohlen, P. Tumor necrosis factor type α, a potent inhibitor of endothelial growth in vitro, is angiogenic in vivo. Proc. Natl. Acad. Sci. USA 84, 5277–5281 (1987).

    Article  Google Scholar 

  30. Subramanian, N. & Bray, M.A. Interleukin 1 releases histamine from human basophils and mast Cells in vitro. J. Immunol. 138, 271–275 (1987).

    CAS  PubMed  Google Scholar 

  31. Arnaout, M.A., Wang, E.A., Clark, S.C. & Sieff, C.A. Human recombinant granulocyte-macrophage colony-stimulating factor increases Cell-to-Cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes. J. Clin. Invest. 78, 597–601 (1986).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Powrie, F., Leach, M.W., Mauze, S., Caddie, L.B. & Coffman, R.L. Phenotypically distinct subsets of CD4+ T Cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice. Int. Immunol. 5, 1461–1471 (1993).

    Article  CAS  PubMed  Google Scholar 

  33. Forman, J., Riblet, R., Brooks, K., Vitetta, S. & Henderson, L.A. H-40, an antigen controlled by an IgH linked gene and recognized by cytotoxic T lymphocytes. I. Genetic analysis of H-40 and distribution of its product on B Cell tumors. J. Exp. Med. 159, 1724–1740 (1984).

    Article  CAS  PubMed  Google Scholar 

  34. Nickoloff, B.J., Kunkel, S.L., Burdick, M. & Stricter, R.M. Severe combined immunodeficiency mouse and human psoriatic skin chimeras: Validation of a new animal model. Am. J. Pathol. 146, 580–588 (1995).

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Mueller, W. & Herrmann, B. Cyclosporin A for psoriasis. N. Engl. J. Med. 301, 555 (1979).

  36. Ellis, C.N. et al. Cyclosporine improves psoriasis in a double-blind study. J. Am. Med. Assoc. 256, 3110–3116 (1986).

    Article  CAS  Google Scholar 

  37. Tomfohrde, J. et al. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 264, 1141–1145 (1994).

    Article  CAS  PubMed  Google Scholar 

  38. Eedy, D.J., Burrows, D., Bridges, J.M. & Jones, F.G.C. Clearance of severe psoriasis after allogeneic bone marrow transplantation. Br. Med. J. 300, 908 (1990).

  39. Nicolas, J.F. et al. CD4 antibody treatment of severe psoriasis. Lancet 338, 321 (1991).

    Article  CAS  Google Scholar 

  40. Prinz, J. et al. Chimaeric CD4 monoclonal antibody in treatment of generalized pustular psoriasis. Lancet 338, 320–321 (1991).

    Article  CAS  PubMed  Google Scholar 

  41. Onuma, S. Immunohistochemical studies of infiltrating Cells in early and chronic lesions of psoriasis. J. Dermatol. 21, 223–232 (1994).

    Article  CAS  PubMed  Google Scholar 

  42. Chang, J.C.C. et al. CD8+ T Cells in psoriatic lesions preferentially use T-Cell receptor Vβ3 and/or Vβ13.1 genes. Proc. Natl. Acad. Sci. USA 91, 9282–9286 (1994).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Gilliam, A.C. & Murphy, G.F. Cutaneous graft-versus-host disease. in Graft-vs.-Host Disease, (eds. Ferrara, J.L.M., Deeg, H.J. & Burakoff, S.J.) 291–313 (Marcel Dekker, New York, 1996).

    Google Scholar 

  44. Schlegel, P.G., Vaysburd, M., Chen, Y., Butcher, E.C. & Chao, N.J. Inhibition of T Cell costimulation by VCAM-1 prevents murine graft-versus-host disease across minor histocompatibility barriers. J. Immunol. 155, 3856–3865 (1995).

    CAS  PubMed  Google Scholar 

  45. Murphy, G.F., Sueki, H., Teuscher, C., Whitaker, D., & Korngold, R. Role of mast Cells in early epithelial target Cell injury in experimental acute graft-versus-host disease. J. Invest. Dermatol. 102, 451–461 (1994).

    Article  CAS  PubMed  Google Scholar 

  46. Gilliam, A.C., Whitaker-Menezes, D., Korngold, R. & Murphy, G.F. Apoptosis is the predominant form of epithelial target Cell injury in acute experimental graft-versus-host disease. J. Invest. Dermatol. 107, 377–383 (1996).

    Article  CAS  PubMed  Google Scholar 

  47. Korngold, R. & Sprent, J. Variable capacity of L3T4+ T Cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice. J. Exp. Med. 165, 1552–1557 (1987).

    Article  CAS  PubMed  Google Scholar 

  48. Townsend, R.M., Briggs, C., Marini, J.C., Murphy, G.F. & Korngold, R. Inhibitory effect of a CD4-CDR3 peptide analog on graft-versus-host disease across a major histocompatibility complex-haploidentical barrier. Blood 88, 3038–3047 (1996).

    CAS  PubMed  Google Scholar 

  49. Powrie, F., Carlino Leach, M.W., Mauze, S. & Coffman, R.L. A critical role for transforming growth factor b but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RBIow CD4+ T Cells. J. Exp. Med. 183, 2669–2674 (1996).

    Article  CAS  PubMed  Google Scholar 

  50. Menssen, A. et al. Evidence for an antigen-specific Cellular immune response in skin lesions of patients with psoriasis vulgaris. J. Immunol. 155, 4078–4083 (1995).

    CAS  PubMed  Google Scholar 

  51. Yam, L.T., Li, C.Y., St Crosby, W.H. Cytochemical identification of monocytes and granulocytes. Am. J. Clin. Pathol. 55, 283–290 (1971).

    Article  CAS  PubMed  Google Scholar 

  52. Brown, L.F. et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J. Invest. Dermatol. 104, 744–749 (1995).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

SchÖn, M., Detmar, M. & Parker, C. Murine psoriasis-like disorder induced by naive CD4+ T cells. Nat Med 3, 183–188 (1997). https://doi.org/10.1038/nm0297-183

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0297-183

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing